• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Using gabapentin to reduce feline stress

April 13, 2023
Roshica Dehaney, PharmD candidate

Administering the anticonvulsant drug can lead to calmer veterinary visits

Gabapentin has demonstrated benefit for calming cats during veterinary visits in several studies on the drug’s veterinary use. An anticonvulsant therapy, gabapentin is largely prescribed by veterinarians for managing pain, and controlling seizures in animals.1

The use of gabapentin was found to be a safe and effective treatment for cats for reducing stress and aggression in a 2017 study published in the Journal of American Veterinary Medical Association (JAVMA). Investigators from Europe and California had examined the drug as a possible key to successful veterinarian visits for felines.2

Advertisement

In a second study, published in a 2018 issue of Journal of Feline Medicine and Surgery, investigators in North Carolina concluded 50 mg or 100 mg gabapentin (9.2–47.6 mg/ kg per cat) reduces fear responses in confined community cats without measurable sedation over 3 hours post administration vs placebo.3

A third study, published in a 2021 issue of JAVMA, found oral administration of gabapentin to cats 2 hours before a veterinary visit can reduce fear-aggression behavior during a physical examination. This study set out to investigate the effect of giving a single dose of gabapentin for fear-based aggressive behaviors in cats during veterinary visits. The researchers compared a dose of either 100 or 200 mg/cat to placebo capsules 2 hours prior to the vet visit. Correlations between favorable outcomes were measured based on compliance scores. The compliance scores included a standardized 9-step protocol (measured 0-9 based on the highest step completed) and an ease of administration (scored 1[very difficult] to 4[very easy]).4

In the same study, the most commonly reported adverse effects include drowsiness, muscle relaxation and impaired balance/coordination. All adverse effects usually resolved within 10 hours or less upon initial observation. Furthermore, most owners reported that the capsules were simple to use and that any side effects were gone within 10 hours. However, in cats with kidney disease, these gabapentin doses should be used with caution.4

From the standpoint of animal welfare, there is still room for educating veterinarians and owners to use all appropriate methods available to help alleviate anxiety and fear associated with veterinary visits for cats. Gentle handling and carrier training are examples of such techniques, but they cannot always be implemented successfully without medication.

Roshica Dehaney is a 2023 PharmD candidate at the University of Connecticut School of Pharmacy in Storrs, CT.

References

  1. Ware E. Gabapentin for dogs, cats, and horses (foals). Wedgewood Pharmacy. July 13, 2022. Accessed April 13, 2023. https://www.wedgewoodpharmacy.com/medications/gabapentin/
  2. van Haaften KA, Eichstadt Forsythe LR, Stelow EA, Bain MJ. Effects of a single preappointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination. J Am Vet Med Assoc. 2017;251(10):1175–1181.
  3. Pankratz KE, Ferris KK, Griffith EH, Sherman BL. Use of single-dose oral gabapentin to attenuate fear responses in cage-trap confined community cats: a double-blind, placebo-controlled field trial. J Feline Med Surg. 2018;20(6):535-543. doi:10.1177/1098612X17719399
  4. Kruszka M, Graff E, Medam T, Masson S. Clinical evaluation of the effects of a single oral dose of gabapentin on fear-based aggressive behaviors in cats during veterinary examinations. J Am Vet Med Assoc. 2021;259(11):1285-1291. doi:10.2460/javma.20.06.0307

Related Content:

PharmacyBehavior
FDA and European Union expand Mutual Recognition Agreement to include animal drugs
FDA and European Union expand Mutual Recognition Agreement to include animal drugs
Drug for acute onset of canine pancreatitis is launched on the US market
Drug for acute onset of canine pancreatitis is launched on the US market
Gene therapy demonstrates benefit to dogs with myxomatous mitral valve disease
Gene therapy demonstrates benefit to dogs with myxomatous mitral valve disease

Advertisement

Latest News

Shelters United to launch beta test for pet adoption app and website

Locoregional analgesia for pain management in veterinary medicine

Outside toxicology experts can save pets’ lives

Lyon College School of Veterinary Medicine names founding dean

View More Latest News
Advertisement